Minocycline in ALS Trial Seeks Participants

There are openings for participants in a large, multicenter trial of minocycline, an antibiotic in the tetracycline family, in amyotrophic lateral sclerosis (ALS). Minocycline has anti-inflammatory and neuroprotective properties and penetrates the central nervous system.

At sites throughout the United States, minocycline is being tested against a placebo (inert substance) in 400 adults with ALS and fairly good respiratory function. Patients taking riluzole can participate if the riluzole dose is stable.

For details and contact information, see: www.mda.org/research/view_ctrial.aspx?id=84